MA SONGJIANG (President) sold 0.1% of their position (4K shares) of GYRE THERAPEUTICS, INC. on the open market
Open‑market sale worth $46.3K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 3/13/2025ACC: 0001140361-25-008623
DirectorOfficer· President
Since Oct 2023
-4K
Net shares
Net seller
$46.3K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
4K disposed
Non-Derivative Transactions2
Common Stock
Indirect
Shares
−2K
Price / share
$11.40
Trade value
$22.80K
% of position
0.1%
3/11/2025
2.84M→2.84M
Common Stock
Indirect
Shares
−2K
Price / share
$11.74
Trade value
$23.48K
% of position
0.1%
3/12/2025
2.84M→2.84M
Total
Net shares
−4K
Net value
-$46.28K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 3/11/2025 | S · Sale | −2K | $11.40 | $22.80K | 0.1% | 2.84M | 2.84M |
| Common Stock Indirect | 3/12/2025 | S · Sale | −2K | $11.74 | $23.48K | 0.1% | 2.84M | 2.84M |
| Total | −4K | -$46.28K | ||||||
Derivative Transactions0
No derivative transactions reported